Hydroxychloroquine therapy of diffuse pulmonary sarcoidosis in two Australian male children

J M Hilton1, D M Cooper, R L Henry

  • 1Department of Paediatrics, John Hunter Hospital, New Lambton, New South Wales, Australia.

Respirology (Carlton, Vic.)
|March 1, 1997
PubMed

Insights

Pediatric sarcoidosis is rare, affecting multiple systems. Two Caucasian boys in Australia with pulmonary sarcoidosis responded well to hydroxychloroquine after initial steroid treatment.

Area of Science:

  • Pediatric Pulmonology
  • Rheumatology
  • Immunology

Background:

  • Sarcoidosis is a multisystem granulomatous disease with unknown incidence in children.
  • Pediatric sarcoidosis prevalence varies by age, race, and geography.
  • Limited research exists on sarcoidosis in Australian children.

Observation:

  • Two Caucasian male children in Australia presented with diffuse pulmonary sarcoidosis.
  • Diffuse pulmonary sarcoidosis is exceptionally rare in non-Scandinavian white children.
  • The cases were observed during the winter of 1992 at John Hunter Hospital.

Findings:

  • Both pediatric patients responded positively to hydroxychloroquine therapy.
  • Initial treatment with steroids showed a good response before transitioning to hydroxychloroquine.
  • This suggests hydroxychloroquine as a potential treatment for pediatric pulmonary sarcoidosis.

Implications:

  • Highlights the possibility of rare pediatric sarcoidosis cases in diverse geographical locations.
  • Suggests hydroxychloroquine as an effective treatment option for pediatric pulmonary sarcoidosis.
  • Underscores the need for further research into pediatric sarcoidosis epidemiology and treatment.

Related Concept Videos